Fighting cancer, New Technology Brings Hopeful Results

A vital moment to understand how medical technology is progressing in the fight against various forms of cancer, with the presentation of new studies that have resulted in a wave of rational optimism from the scientific community.

One of the best news comes from the front of the breast tumor, one of the most frequent, is to assume that 2.3 million women were diagnosed in 2020 alone, with almost 700 thousand victims. But the Dustin-Breast04 study, presented during the conference with enthusiasm and cheers from those present, has calculated that the new generation medicine called transtuzumab deruxteccan, has almost doubled cases of non-proliferation survival and a 36% reduction in the risk of death.

According to experts, the study of 557 women on medicine that has been adopted in the US in 2019 and the EU in 2021 will revolutionise clinical practice, reducing unwanted effects and in the future can replace conventional chemotherapy, even in other forms of cancer such as lungs, intestines and wombs.

Good results have also presented studies based on immunotherapy, especially on melanomas and lung cancer. Practically, immunotherapy aims to awaken the patient's immune defense, including traditional chemotherapy a drug like Relatlimab and Nivolumb. According to the study, this balance brings up to 80% of the risk of a resurface of cancer, following surgical intervention.

Similar treatment has also produced good results in esophagus tumors, which has one of the highest mortality rates. Named practically without healing, this heavy form of recent methodologies has provided research with a double survival period, which dissemination did not exceed 10 months. /a2cn

Sweet delivery